Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 24971-24980 Newer>

The Motley Fool July 30, 2007 Alyce Lomax	Volcom Wipes Out ... Again Given expectations for impressive growth from Volcom, the fact that the stock trades at 19 times forward earnings doesn't sound unreasonable.
The Motley Fool July 30, 2007 Jeremy MacNealy	Fool on Call: Panera's Cooking Up Changes The restaurateur sees plenty of room for improvement. Investors, the uncertainty might provide just the opportunity to take a closer look at what still remains a compelling long-term growth story.
The Motley Fool July 30, 2007 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies that have just raised their dividends: Anheuser-Busch... Time Warner... Northern Suffolk... etc.
The Motley Fool July 30, 2007 Rick Aristotle Munarriz	YouTube Fingers a Solution Google's video-sharing site finally closes in on copyright protection. Can YouTube be monetized effectively? Investors, take note.
The Motley Fool July 30, 2007 Brian Lawler	AtheroGenics Follows a New Route AtheroGenics gives more details on the path forward for its lead drug. The drugmaker is trading at a low $70 million valuation, but investors who buy into shares today shouldn't get their hopes up for the outcome.
The Motley Fool July 30, 2007 Brian Orelli	Palomar Plummets In the second quarter, cosmetic-laser maker Palomar Medical Technology had a stellar performance in the former, but investors couldn't look past the lack of royalty payments.
The Motley Fool July 30, 2007 Brian Orelli	Mega Mylan Is on Track Comparing year-over-year results for Mylan will continue to be complicated for the next year and a half or so. It's one merger down, one to go for the generic drug company. Investors, take note.
The Motley Fool July 30, 2007 Brian Lawler	Is Glaxo's Avandia Down for the Count? An FDA advisory committee is set to debate one of Glaxo's top compounds. What will it mean to investors?
The Motley Fool July 30, 2007 Toby Shute	Suncor Builds Some More Let's sift through the giant oil sands player's quarterly results, shall we? Investors, if you want to play in the oil sand(s)box, Suncor is the way to do it.
The Motley Fool July 30, 2007 Brian Lawler	The Good and Bad of Elan Investors, any bet on Elan is primarily a bet on the outcomes of Tysabri and AAB-001.
<Older 24971-24980 Newer> Return to current articles.